Angiotensin receptor blockers and COVID-19

Angiotensin Receptor Blockers (ARBs) exhibit major pleiotropic protecting effects beyond their antihypertensive properties, including reduction of inflammation. ARBs directly protect the lung from the severe acute respiratory syndrome as a result of viral infections, including those from coronavirus...

Descripción completa

Detalles Bibliográficos
Autor principal: Saavedra, Juan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158830/
https://www.ncbi.nlm.nih.gov/pubmed/32304747
http://dx.doi.org/10.1016/j.phrs.2020.104832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158830/
https://www.ncbi.nlm.nih.gov/pubmed/32304747
http://dx.doi.org/10.1016/j.phrs.2020.104832

Ejemplares similares